“Cannabidiol (CBD) decreases insulitis, inflammation, neuropathic pain and myocardial dysfunction in preclinical models of diabetes.
We recently showed that CBD also improves vasorelaxation in the Zucker Diabetic fatty (ZDF) rat, and the objective of the present study was to establish the mechanisms underlying this effect…
CBD exposure enhances the ability of arteries to relax via enhanced production of vasodilator COX 1/2-derived products acting at EP4 receptors.”